Prevention and treatment of Heart Failure in patients with and without diabetes
Topics
- Understanding the prevalence, burden and impact of HF both in patients living with and without T2D
- Understand which patients are at risk of HF and highlight importance of preventing HF
- Review the evidence and guideline recommendations on treatment of patients with HF to reduce the risk of disease progression and improve mortality outcomes
- Symptoms, Physical examination, ECG (if available) check the rhythm and heart rate , Blood tests, Drug interactions related reviewing the medications used by the patient, Recommendations and making an appointment for the next health check
Learning Objectives
- Learn how to identify your at-risk patients
- Discuss the new evidence-based treatments that can prevent HF
- Get updated on the new guideline directed medical therapies available to treat HF
- Learn how to improve outcomes and QoL in patients with HF with and without T2D
Moderator
Prof Mehmet Ungan
Speakers
Prof. Sadi Gulec
Professor of Cardiology at the Ankara University, School of Medicine, Cardiology Department, Turkey
Sadi Güleç is a Professor of Cardiology at the Ankara University School of Medicine. He has done some work with the Cleveland Clinic Foundation, USA. He is a member of the European Society of Cardiology and Turkish Society of Cardiology. He has served in the Scientific Board as well as in working groups of the Turkish Society of Cardiology. He currently is the vice president of Turkish Metabolic Syndrome Society. He has taken part in several national and multinational studies. He has over 100 publications on topics such as cardiovascular diseases, hypertension and high cholesterol and has authored the book “Hmm! dedi doktor; Anjiyo olmanız gerekiyor.”
Prof. Richard Hobbs
Professor of Primary Care Health Sciences, NIHR English School for Primary Care Research, Oxford, UK
Richard Hobbs is Nuffield Professor of Primary Care at the University of Oxford, and Head of the Nuffield Department of Primary Care Health Sciences. He has served a decade as National Director of the National Institute for Health Research’s School for Primary Care Research and was Director of the NHS Quality and Outcomes Framework (QOF) Review panel from 2005-09. He has served many national and international scientific and research funding boards in UK, Ireland, Canada, and WHO, including the BHF Council, British Primary Care Cardiovascular Society, and the ESC Council for Cardiovascular Primary Care. He currently chairs the European Primary Care Cardiovascular Society, a WONCA Special Interest Group.
This webinar is supported by an unrestricted educational grant from AstraZeneca.